Event Series AI Summit Agenda 2023

Breakfast

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Join your colleagues from around the globe as we kick off the AI Summit with a complimentary hot breakfast!

Event Series AI Summit Agenda 2023

Lunch

Sit with FDA officials, speakers, industry experts, and your colleagues at tables dedicated to topics that are important to you. Enjoy the discussion while sharing a meal together!

Event Series AI Summit Agenda 2023

Emerging AI Applications and the AI Health Ecosystem

Moderators: Steve Frigon, Data Integration Team Lead, The Christ Hospital Health Network; Lacey Harbour, Regulatory Affairs Manager, Thermo Fisher Scientific
Speakers: Bakul Patel, Senior Director, Global Digital Health Strategy & Regulatory Google; Gary Turner, Managing Director, Additive Manufacturing North America, Ricoh USA, Inc

Event Series AI Summit Agenda 2023

Fireside Chat: AI Regulators & Policy Makers

Moderator: Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding
Speakers: Laura Adams, Senior Advisor, National Academy of Medicine (NAM);
Dr. Brian Anderson, Chief Digital Health Physician, Mitre | CO-Founder, Coalition for Health AI (CHAI);
Bakul Patel, Senior Director, Global Digital Health Strategy & Regulatory, Google
Troy Tazbaz, Director of Digital Health, Center for Devices and Radiological Health (CDRH), FDA

Event Series AI Summit Agenda 2023

Breakfast

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Join your colleagues from around the globe as we kick off the AI Summit with a complimentary hot breakfast!

Event Series AI Summit Agenda 2023

Day 2 Open

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Moderator: Timothy W. Hsu, Chief Collaboration Officer, AFDO/RAPS Healthcare Products Collaborative

Event Series AI Summit Agenda 2023

AI in Action

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Moderator: Cindy Ipach, President & CEO, Compliance Insight
Speakers:
Craig Douglass, Co-founder and CEO of Contact CI
Douglas Fagaly, Co-Founder, Chief Strategy Officer, E Tech Group
Thomas Friedli, Director, Institute of Technology Management, University of St. Gallen

Event Series AI Summit Agenda 2023

Lunch

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Sit with FDA officials, speakers, industry experts, and your colleagues at tables dedicated to topics that are important to you. Enjoy the discussion while sharing a meal together!

Event Series AI Summit Agenda 2023

Breakfast

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Join your colleagues from around the globe as we kick off the AI Summit with a complimentary hot breakfast!

Event Series AI Summit Agenda 2023

Day 3 Open

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Moderator: Timothy W. Hsu, Chief Collaboration Officer, AFDO/RAPS Healthcare Products Collaborative

Event Series AI Summit Agenda 2023

Fireside Chat

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Matt Diamond, Chief Medical Officer, Digital Health Center of Excellence, FDA
Suchi Saria, CEO & Founder, Chief Scientific Officer, Bayesian Health

Event Series AI Summit Agenda 2023

Transparency vs. Explainability: Practicalities, Benefits, and Issues

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Moderator: Matt Schmucki, Associate Director of Automation Engineering, Vertex Pharmaceuticals
Speaker: Hussein Ezzeldin, Senior Staff Fellow, Center for Biologics Evaluation and Research (CBER), FDA; Shawn Forrest, Biomedical Engineer, Center for Devices and Radiological Health (CDRH), FDA; Mike Salem, Associate Director of Data Science - Quality Assurance, Gilead Sciences

Event Series AI Summit Agenda 2023

FDA’s PCCP Draft Guidance Deep Dive

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Moderator: Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding
Speakers: Alex Cadotte, Senior Director, Digital Health and Imaging, MCRA; MiRa Jacobs, Acting Assistant Director, Digital Health Policy, Digital Health Center of Excellence at FDA; Cassie Scherer, Senior Director US Regulatory and Global Digital Health Policy, Medtronic

Event Series AI Summit Agenda 2023

Lunch

The Westin Cincinnati 21 E 5th Street, Cincinnati, OH, United States

Sit with FDA officials, speakers, industry experts, and your colleagues at tables dedicated to topics that are important to you. Enjoy the discussion while sharing a meal together!

Notified Body Opinion Workshop – Experiences and Lessons for Combination Products in EU

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Leading Facilitators: Ryan McGowan, Director, Digital Devices and Combination Products, AstraZeneca; James Wabby, Global Head – Emerging Technologies, Combination Products, and Devices, Abbvie
Facilitators: Arabe Ahmed, Bsi Group; Timothy Chesworth, Senior Director Regulatory Affairs - Devices & Digital Therapeutic, AstraZeneca; Katie Chowdhury, Director, Global Regulatory Affair, Emerging Technologies, Digital Medical Devices, & Combination Products, AbbVie; Amanda Matthews, Senior Director, Regulatory CMC for Combination Products & Medical Devices, Pfizer

Combination Products Risk Management: Integration of ICH Q9(R1) and ISO 14971:2019

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Leading Facilitators: Tine Albeck, Senior Quality Assurance Professional, ALK A/S
Facilitators: Susan Neadle, Principal Consultant and President, Combination Products Consulting, LLC; Rick Wedge, Compliance Lead / Associate Research Fellow, Pfizer; Milind Ganjawala, Division Director of Drug Quality II, Center for Drug Evaluation and Research (CDER), FDA

Risk management application in post-market safety & other PMSR Hot topics

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Leading Facilitators: Khaudeja Bano, Vice President, Combination Product Quality, Amgen; Rich Wolf, Head of Pv Operations at CSL Behring
Facilitators: John "Barr" Weiner, Associate Director for Policy in FDA’s Office of Combination Products (OCP), FDA; Fubin Wu, Co-founder, GessNet Safety Engineering; Kate Gillespie, Sr. Director, Global Product Vigilance and Post Market Reporting, Johnson & Johnson

From the Desk of the Office of Combination Products: Strategic Priorities & Action

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Moderator: Timothy W. Hsu, Chief Collaboration Officer, AFDO/RAPS Healthcare Products Collaborative
Speakers: James Bertram, Director of the Office of Combination Products (OCP), FDA; John "Barr" Weiner, Associate Director for Policy in FDA’s Office of Combination Products (OCP), FDA

Global Harmonization Opportunities in Combination Products

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Moderators: Susan Neadle, Principal Consultant and President, Combination Products Consulting, LLC; Khaudeja Bano, VP Combination Product Quality, Amgen
Speakers: Stiina Aarum, Scientific Officer, Scientific Advice and Protocol Assistance, European Medicines Academy(EMA); Theresa Jeary, Principal Technical Specialist, Medicinal & Biologics, BSI; Joo Hee Kim Professor, Regulatory Strategy center for Combination Products (RSCP), Ajou University; Mike Wallenstein, Global Head Regulatory Medical Devices, Combination Products & Precision Medicine, Novartis; John "Barr" Weiner, Associate Director for Policy in FDA’s Office of Combination Products (OCP), FDA

Platform Drug-Delivery Devices: Regulatory and Technical Considerations

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Moderator: Chin-Wei Soo, Global Regulatory Head - CMC/Devices and Combination Products, Genentech
Speakers: Jiaying Shen, Distinguished Scientist, Merck; Kent Abrahamson, Director, Combination Product and Device Development, Abbvie; James Bertram, Director of the Office of Combination Products (OCP), FDA; Patricia Love, Deputy Director, FDA’s Office of Combination Products (OCP), FDA (Invited)

Lunch

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Sit with FDA officials, speakers, industry experts, and your colleagues at tables dedicated to topics that are important to you! Enjoy the discussion while sharing a meal together!

Evolution of Essential Performance Requirements

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Moderator: Rumi Young, Director, Regulatory Policy, BD
Speakers: Matthew Ondeck, Senior Manager Regulatory Affairs, Regeneron Pharmaceuticals; Subhi Saadeh, Sr. Manager - Combination Products QA, Gilead Sciences; Ashley Boam, Director, Office of Policy, Center for Drug Evaluation and Research (CDER), FDA; Sarah Mollo, Combination Products Analyst, Center for Devices and Radiological Health (CDRH), FDA; Alan Stevens, Global Head of Complex Devices and Drug Delivery Systems, RA CMC
Devices, AbbVie

Use of Emerging Digital Health Technologies for Combination Products

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Moderators: Ryan McGowan, Director, Digital Devices and Combination Products, AstraZeneca; Ryan Hoshi, Director, Regulatory Policy and Intelligence at AbbVie
Speakers: Katie Chowdhury,Director, Global Regulatory Affair, Emerging Technologies, Digital Medical Devices, & Combination Products, AbbVie; MiRa Jacobs, Acting Assistant Director, Digital Health Policy, Digital Health Center of Excellence at FDA; Kristina Lauritsen, Combination Products Regulator, Center for Drug Evaluation and Research (CDER), FDA; Ryan McGowan, Director, Digital Devices and Combination Products, AstraZeneca; Andrew Yeatts, Combination Product Policy Analyst, Center for Devices and Radiological Health (CDRH), FDA

Next-Generation Combination Products

Omni Fort Worth Hotel 1300 Houston Street, Fort Worth, Texas, United States

Moderators: Susan Neadle, Principal Consultant and President, Combination Products Consulting, LLC; Sandy Boyd, Independent Consultant
Speakers: Dan Groszmann, Director of Engineering, Amgen; Geoff Hamilton , Chief Executive Officer, Stemson Therapeutics; Steven Oh, Deputy Office Director, Office of Cellular Therapy and Human Tissue, Center for Biologics Evaluation and Research (CBER), FDA; James Wabby, Global Head, Regulatory Affairs (CoE) - Emerging Technologies, Devices, and Combination Products & Volwiler Senior Research Industry Fellow - Regulatory Science, Abbvie;